Skip to main content
SpringerLink
Log in

Deubiquitinase BRCC3 promotes the migration, invasion and EMT progression of colon adenocarcinoma by stabilizing MET expression

  • Research Article
  • Published:
Genes & Genomics Aims and scope Submit manuscript

Abstract

Background

Breast cancer type 1 susceptibility protein/breast cancer type 2 susceptibility protein-containing complex subunit 3 (BRCC3), a deubiquitinase (DUBs), is overexpressed in various cancers. However, the underlying biological roles of BRCC3 in adenocarcinoma colon (COAD) have yet to be decrypted.

Objective

In this work, we explored the potential biological function of BRCC3 in the natural process of COAD cells.

Methods

The expression levels of BRCC3 in COAD tissues and cell lines were investigated via quantitative real time polymerase chain reaction and western blotting analyses. Meanwhile, short hairpin RNAs targeting BRCC3 (sh-BRCC3) or mesenchymal-epithelial transition factor (MET) (sh-MET) were used to investigate the biological function, including proliferation, apoptosis, migration, invasion, and epithelial–mesenchymal transition (EMT) progression in COAD cells. Furthermore, the expression levels of EMT-related biomarkers were detected with western blotting analysis. Furthermore, we also performed Co-IP assay to identify the correlation between BRCC3 and MET.

Results

BRCC3 expression was increased in COAD tissues and cell lines. ShRNA-mediated downmodulation of BRCC3 in COAD cell lines induced EMT progression. BRCC3 knockdown resulted in decreased migration as well as invasion and increased apoptosis of SW480 and Lovo cells. Besides, MET was regulated by BRCC3 and involved in the migration, invasion, and EMT in SW480 and Lovo cells. Finally, we uncovered that the overexpressed MET reversed the effects of BRCC3 knockdown in COAD cell development.

Conclusions

BRCC3 acted as a critical factor in the development of COAD by deubiquitinating and stabilizing MET, which might provide an emerging biomarker for the therapeutic and diagnosis strategy of COAD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Barata-Antunes C, Alves R, Talaia G, Casal M, Geros H, Mans R, Paiva S (2021) Endocytosis of nutrient transporters in fungi: the ART of connecting signaling and trafficking. Comput Struct Biotechnol J 19:1713–1737

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Boromand N, Hasanzadeh M, ShahidSales S, Farazestanian M, Gharib M, Fiuji H, Behboodi N, Ghobadi N, Hassanian SM, Ferns GA et al (2018) Clinical and prognostic value of the C-Met/HGF signaling pathway in cervical cancer. J Cell Physiol 233:4490–4496

    Article  CAS  PubMed  Google Scholar 

  • Bryan S, Masoud H, Weir HK, Woods R, Lockwood G, Smith L, Brierley J, Gospodarowicz M, Badets N (2018) Cancer in Canada: stage at diagnosis. Health Rep 29:21–25

    PubMed  Google Scholar 

  • Chebouti I, Kasimir-Bauer S, Buderath P, Wimberger P, Hauch S, Kimmig R, Kuhlmann JD (2017) EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy. Oncotarget 8:48820–48831

    Article  PubMed  PubMed Central  Google Scholar 

  • Cooper EM, Boeke JD, Cohen RE (2010) Specificity of the BRISC deubiquitinating enzyme is not due to selective binding to Lys63-linked polyubiquitin. J Biol Chem 285:10344–10352

    Article  CAS  PubMed  Google Scholar 

  • Czyz M (2018) HGF/c-MET signaling in melanocytes and Melanoma. Int J Mol Sci 19

  • Dongre A, Weinberg RA (2019) New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol 20:69–84

    Article  CAS  PubMed  Google Scholar 

  • Du F, Li X, Feng W, Qiao C, Chen J, Jiang M, Qiu Z, Qian M, Tian D, Nie Y et al (2020) SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET. Oncogene 39:3522–3540

    Article  CAS  PubMed  Google Scholar 

  • Fabregas JC, Ramnaraign B, George TJ (2022) Clinical updates for Colon Cancer Care in 2022. Clin Colorectal Cancer 21:198–203

    Article  PubMed  Google Scholar 

  • Fu J, Su X, Li Z, Deng L, Liu X, Feng X, Peng J (2021) HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence. Oncogene 40:4625–4651

    Article  CAS  PubMed  Google Scholar 

  • Gu YY, Yang M, Zhao M, Luo Q, Yang L, Peng H, Wang J, Huang SK, Zheng ZX, Yuan XH et al (2015) The de-ubiquitinase UCHL1 promotes gastric cancer metastasis via the akt and Erk1/2 pathways. Tumour Biol 36:8379–8387

    Article  CAS  PubMed  Google Scholar 

  • Harper JW, Elledge SJ (2007) The DNA damage response: ten years after. Mol Cell 28:739–745

    Article  CAS  PubMed  Google Scholar 

  • Hu Y, Zhang Y, Ding M, Xu R (2021) Long noncoding RNA TMPO-AS1/miR-126-5p/BRCC3 axis accelerates gastric cancer progression and angiogenesis via activating PI3K/Akt/mTOR pathway. J Gastroenterol Hepatol 36:1877–1888

    Article  CAS  PubMed  Google Scholar 

  • Huang D, Nagata Y, Grossmann V, Radivoyevitch T, Okuno Y, Nagae G, Hosono N, Schnittger S, Sanada M, Przychodzen B et al (2015) BRCC3 mutations in myeloid neoplasms. Haematologica 100:1051–1057

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kallergi G, Markomanolaki H, Giannoukaraki V, Papadaki MA, Strati A, Lianidou ES, Georgoulias V, Mavroudis D, Agelaki S (2009) Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients. Breast Cancer Res 11:R84

    Article  PubMed  PubMed Central  Google Scholar 

  • Kim HJ (2022) Therapeutic strategies for ovarian Cancer in point of HGF/c-MET targeting. Med (Kaunas) 58

  • Lawal B, Wang YC, Wu ATH, Huang HS (2021) Pro-oncogenic c-Met/EGFR, Biomarker signatures of the Tumor Microenvironment are clinical and Therapy Response prognosticators in Colorectal Cancer, and therapeutic targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione derivatives. Front Pharmacol 12:691234

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liew SK, Azmi MN, In L, Awang K, Nagoor NH (2017) Anti-proliferative, apoptotic induction, and anti-migration effects of hemi-synthetic 1’S-1’-acetoxychavicol acetate analogs on MDA-MB-231 breast cancer cells. Drug Des Devel Ther 11:2763–2776

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lu W, Kang Y (2019) Epithelial-mesenchymal plasticity in Cancer Progression and Metastasis. Dev Cell 49:361–374

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lv S, Wang X, Bai X, Ning H, Li Y, Wen H, Lu W, Wang J (2020) Mesenchymal epithelial transition factor regulates tumor necrosis factor-related apoptotic induction ligand resistance in hepatocellular carcinoma cells through down-regulation of cyclin B1. Int J Biochem Cell Biol 128:105844

    Article  CAS  PubMed  Google Scholar 

  • Malik R, Mambetsariev I, Fricke J, Chawla N, Nam A, Pharaon R, Salgia R (2020) MET receptor in oncology: from biomarker to therapeutic target. Adv Cancer Res 147:259–301

    Article  CAS  PubMed  Google Scholar 

  • Meyer T, Jahn N, Lindner S, Rohner L, Dolnik A, Weber D, Scheffold A, Kopff S, Paschka P, Gaidzik VI et al (2020) Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1). Leukemia 34:404–415

    Article  CAS  PubMed  Google Scholar 

  • Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, Kramer J, Siegel RL (2022) Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 72:409–436

    Article  PubMed  Google Scholar 

  • Ning Y, Zhang W, Hanna DL, Yang D, Okazaki S, Berger MD, Miyamoto Y, Suenaga M, Schirripa M, El-Khoueiry A et al (2018) Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patients. Pharmacogenomics J 18:29–34

    Article  CAS  PubMed  Google Scholar 

  • Niu T, De Rosny C, Chautard S, Rey A, Patoli D, Groslambert M, Cosson C, Lagrange B, Zhang Z, Visvikis O et al (2021) NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly. Nat Commun 12:5862

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Okamoto K, Bartocci C, Ouzounov I, Diedrich JK, Yates JR 3rd, Denchi EL (2013) A two-step mechanism for TRF2-mediated chromosome-end protection. Nature 494:502–505

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Paemka L, Mahajan VB, Ehaideb SN, Skeie JM, Tan MC, Wu S, Cox AJ, Sowers LP, Gecz J, Jolly L et al (2015) Seizures are regulated by ubiquitin-specific peptidase 9 X-linked (USP9X), a de-ubiquitinase. PLoS Genet 11:e1005022

    Article  PubMed  PubMed Central  Google Scholar 

  • Pan J, Qiao Y, Chen C, Zang H, Zhang X, Qi F, Chang C, Yang F, Sun M, Lin S et al (2021) USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1. Cell Death Dis 12:1051

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pastushenko I, Blanpain C (2019) EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol 29:212–226

    Article  CAS  PubMed  Google Scholar 

  • Pothula SP, Xu Z, Goldstein D, Pirola RC, Wilson JS, Apte MV (2020) Targeting HGF/c-MET Axis in Pancreatic Cancer. Int J Mol Sci 21

  • Py BF, Kim MS, Vakifahmetoglu-Norberg H, Yuan J (2013) Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol Cell 49:331–338

    Article  CAS  PubMed  Google Scholar 

  • Raj S, Kesari KK, Kumar A, Rathi B, Sharma A, Gupta PK, Jha SK, Jha NK, Slama P, Roychoudhury S et al (2022) Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. Mol Cancer 21:31

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rokavec M, Horst D, Hermeking H (2017) Cellular Model of Colon cancer progression reveals signatures of mRNAs, miRNA, lncRNAs, and Epigenetic Modifications Associated with Metastasis. Cancer Res 77:1854–1867

    Article  CAS  PubMed  Google Scholar 

  • Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA, Jemal A (2020) Colorectal cancer statistics, 2020. CA Cancer J Clin 70:145–164

    Article  PubMed  Google Scholar 

  • Song L, Zhang L, Zhou Y, Shao X, Xu Y, Pei D, Wang Q (2022) ORP5 promotes tumor metastasis via stabilizing c-Met in renal cell carcinoma. Cell Death Discov 8:219

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sun ZZ, Zhang T, Ning K, Zhu R, Liu F, Tang SC, Jiang B, Hua D (2016) B7-H3 upregulates BRCC3 expression, antagonizing DNA damage caused by 5-Fu. Oncol Rep 36:231–238

    Article  CAS  PubMed  Google Scholar 

  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249

    Article  PubMed  Google Scholar 

  • Sylvester PW (2014) Targeting met mediated epithelial-mesenchymal transition in the treatment of breast cancer. Clin Transl Med 3:30

    Article  PubMed  PubMed Central  Google Scholar 

  • Tao H, Liao Y, Yan Y, He Z, Zhou J, Wang X, Peng J, Li S, Liu T (2021) BRCC3 promotes tumorigenesis of bladder Cancer by activating the NF-kappaB signaling pathway through targeting TRAF2. Front Cell Dev Biol 9:720349

    Article  PubMed  PubMed Central  Google Scholar 

  • Vogel JD, Felder SI, Bhama AR, Hawkins AT, Langenfeld SJ, Shaffer VO, Thorsen AJ, Weiser MR, Chang GJ, Lightner AL et al (2022) The American Society of Colon and rectal surgeons Clinical Practice guidelines for the management of Colon cancer. Dis Colon Rectum 65:148–177

    Article  PubMed  Google Scholar 

  • Wang S, Qiu J, Liu L, Su C, Qi L, Huang C, Chen X, Zhang Y, Ye Y, Ding Y et al (2020) CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET. J Exp Clin Cancer Res 39:168

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yao JF, Li XJ, Yan LK, He S, Zheng JB, Wang XR, Zhou PH, Zhang L, Wei GB, Sun XJ (2019) Role of HGF/c-Met in the treatment of colorectal cancer with liver metastasis. J Biochem Mol Toxicol 33:e22316

    Article  PubMed  PubMed Central  Google Scholar 

  • Yilmaz M, Christofori G (2009) EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28:15–33

    Article  PubMed  Google Scholar 

  • Zhang F, Zhou Q (2018) Knockdown of BRCC3 exerts an anti–tumor effect on cervical cancer in vitro. Mol Med Rep 18:4886–4894

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang Y, Xia M, Jin K, Wang S, Wei H, Fan C, Wu Y, Li X, Li X, Li G et al (2018) Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities. Mol Cancer 17:45

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhao R, Cai Z, Li S, Cheng Y, Gao H, Liu F, Wu S, Liu S, Dong Y, Zheng L et al (2017) Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer. Oncotarget 8:9293–9302

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by Nantong Basic Science Research and Social Livelihood Science and Technology Plan Project (No. MSZ2022041).

Author information

Authors and Affiliations

  1. Department of Oncology, Nantong First People’s Hospital and Affiliated Hospital 2 of Nantong University, No.666 Shengli Road, Chongchuan District, Nantong, 226000, Jiangsu, China

    Xiu Feng, Shengnan He, Ying Chen & Liang Zhang

Authors
  1. Xiu Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shengnan He
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ying Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Liang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Ying Chen or Liang Zhang.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Feng, X., He, S., Chen, Y. et al. Deubiquitinase BRCC3 promotes the migration, invasion and EMT progression of colon adenocarcinoma by stabilizing MET expression. Genes Genom 46, 637–646 (2024). https://doi.org/10.1007/s13258-024-01508-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13258-024-01508-8

Keywords

Search

Navigation